{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:54:15Z","timestamp":1791021255521,"version":"4.1.0"},"reference-count":118,"publisher":"Baishideng Publishing Group Inc.","issue":"46","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2005]]},"DOI":"10.3748\/wjg.v11.i46.7227","type":"journal-article","created":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T13:25:18Z","timestamp":1445001918000},"page":"7227","source":"Crossref","is-referenced-by-count":265,"title":["Extraintestinal manifestations in inflammatory bowel disease"],"prefix":"10.3748","volume":"11","author":[{"given":"Silvio","family":"Danese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199607000-00009"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026629528233"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.6.2359"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/gut.27.1.86"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70310-5"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.27968"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041035"},{"key":"ref8","unstructured":"Rutgeers P. ColombelJ, Enns R, et al. Subanalyses from a phase 3 study on the evaluation of natalizumab in active Crohn's disease therapy-1(ENACT-1). Gut 2003;52:A239."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.5.738"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/gut.24.1.38"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9178675"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02044.x"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.35396"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.021774"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-1227 DOI : 10.1002\/art.1780341003.","DOI":"10.1002\/art.1780341003"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/ard.37.1.33"},{"key":"ref17","unstructured":"de Vlam K, Van de Wiele C, Mielants H, Dierckx RA, Veys EM. Is 99mTc human immunoglobulin G scintigraphy (HIG-scan) useful for the detection of spinal inflammation in ankylosing spondylitis? Clin Exp Rheumatol 2000;18:379-382."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780210210"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/gut.42.3.387"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0953-6205(00)00093-5"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02262.x"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05608.x"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780391211"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380507"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1080\/030097401753180318"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.012450"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03239-6"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.06064.x"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.1992.tb05012.x"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.28674"},{"key":"ref31","unstructured":"Marzo-Ortega H, McGonagle D, Emery P. Etanercept treatment in resistant spondyloarthropathy: imaging, duration of effect and efficacy on reintroduction. Clin Exp Rheumatol 2002;20:S175-S177."},{"key":"ref32","unstructured":"Broomé U, Hauzenberger D, Klominek J. Adhesion molecules in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatogastroenterology 1996;43:1109-1112."},{"key":"ref33","unstructured":"Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M, Ricci G. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group. Eur J Gastroenterol Hepatol 1996;8:685-691."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200501000-00009"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8566590"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709025107"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840100406"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.046615"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00288-4"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1080\/003655202760373434"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80253-5"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1159\/000050097"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03777.x"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.27965"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20370"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310005172"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(00)01059-5"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s005350070026"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Bargiggia S, Maconi G, Elli M, Molteni P, Ardizzone S, Parente F, Todaro I, Greco S, Manzionna G, Porro GB. Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: study of 511 subjects at a single center. J Clin Gastroenterol 2003;36:417-420 DOI : 10.1097\/00004836-200305000-00012.","DOI":"10.1097\/00004836-200305000-00012"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2004.03368.x"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.32362"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjgastroenterol.2003.10.007"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08512-4"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030815"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200303000-00003"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02055.x"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/BF02236866"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(03)00080-X"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200308000-00013"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-004-0467-8"},{"key":"ref61","unstructured":"Menachem Y, Gotsman I. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease. Isr Med Assoc J 2004;6:88-90."},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07581.x"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s10227-004-0115-7"},{"key":"ref64","unstructured":"McGowan JW, Johnson CA, Lynn A. Treatment of pyoderma gangrenosum with etanercept. J Drugs Dermatol 2004;3:441-444."},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.4065\/80.4.549"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200403000-00013"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200403000-00012"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.4321\/S0365-66912004000800010"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05514.x"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-201-43485"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-5-11"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-10-200011210-00012"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.2.176"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.09.027"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01317.x"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07590.x"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2002.6510"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1590191"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1002\/art.10097"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07676.x"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.18158"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.16518"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200312000-00003"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 2003;124:791-794.","DOI":"10.1053\/gast.2003.50107"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02057.x"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032066"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.025411"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1080\/003655200750023589"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)65200-8"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1046\/j.1572-0241.2003.04026.x"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03725.x"},{"key":"ref92","unstructured":"Cattaneo M, Vecchi M, Zighetti ML, Saibeni S, Martinelli I, Omodei P, Mannucci PM, de Franchis R. High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications? Thromb Haemost 1998;80:542-545."},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03193.x"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07491.x"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-005-1588-y"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00930.x"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(02)00275-1"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041620116"},{"key":"ref99","doi-asserted-by":"crossref","unstructured":"Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992;79:1987-1994.","DOI":"10.1182\/blood.V79.8.1987.1987"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0136"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.035758"},{"key":"ref102","doi-asserted-by":"crossref","unstructured":"Gasche C, Waldhoer T, Feichtenschlager T, Male C, Mayer A, Mittermaier C, Petritsch W. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. Am J Gastroenterol 2001;96:2382-2387.","DOI":"10.1016\/S0002-9270(01)02657-0"},{"key":"ref103","unstructured":"Gasche C. Complications of inflammatory bowel disease. Hepatogastroenterology 2000;47:49-56."},{"key":"ref104","unstructured":"Caudarella R, Rizzoli E, Pironi L, Malavolta N, Martelli G, Poggioli G, Gozzetti G, Miglioli M. Renal stone formation in patients with inflammatory bowel disease. Scanning Microsc 1993;7:371-379; discussion 371-39;."},{"key":"ref105","unstructured":"Kreisel W, Wolf LM, Grotz W, Grieshaber M. Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease. Eur J Gastroenterol Hepatol 1996;8:461-468."},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05983.x"},{"key":"ref107","unstructured":"Fernández-Castroagudín J, Brage Varela A, Lens Neo XM, Martínez Castro J, Abdulkader I. Renal amyloidosis as initial clinical manifestation of Crohn's disease. Gastroenterol Hepatol 2002;25:395-397."},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00208-7"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-195003000-00006"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996586"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1007\/s001150050547"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(96)00156-6"},{"key":"ref113","doi-asserted-by":"crossref","unstructured":"Nash CL, Panaccione R, Sutherland LR, Meddings JB. Giant cell myocarditis, in a patient with Crohn's disease, treated with etanercept--a tumour necrosis factor-alpha antagonist. Can J Gastroenterol 2001;15:607-611.","DOI":"10.1155\/2001\/954340"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200103000-00017"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200023050-00006"},{"key":"ref116","unstructured":"Baker DE, Kane S. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. Rev Gastroenterol Disord 2004;4:86-91."},{"key":"ref117","unstructured":"Lémann M, Zenjari T, Bouhnik Y, Cosnes J, Mesnard B, Rambaud JC, Modigliani R, Cortot A, Colombel JF. Methotrexate in Crohn's disease: long-term efficacy and toxicity. Am J Gastroenterol 2000;95:1730-1734."},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.07093.x"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v11\/i46\/7227.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T21:55:22Z","timestamp":1599688522000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v11\/i46\/7227.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":118,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v11.i46.7227","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2005]]}}}